109 related articles for article (PubMed ID: 31173764)
1. Caspase-11-Mediated Cell Death Contributes to the Pathogenesis of Imiquimod-Induced Psoriasis.
Kenealy S; Manils J; Raverdeau M; Munoz-Wolf N; Barber G; Liddicoat A; Lavelle EC; Creagh EM
J Invest Dermatol; 2019 Nov; 139(11):2389-2393.e3. PubMed ID: 31173764
[No Abstract] [Full Text] [Related]
2. Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice.
Aira LE; Gonçalves D; Bossowski JP; Rubio-Patiño C; Chiche J; Paul-Bellon R; Mondragón L; Gesson M; Lecucq-Ottavi P; Obba S; Colosetti P; Luciano F; Bailly-Maitre B; Boyer L; Jacquel A; Robert G; Ricci JE; Ortonne JP; Passeron T; Lacour JP; Auberger P; Marchetti S
J Invest Dermatol; 2019 Jun; 139(6):1306-1317. PubMed ID: 30571969
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
4. [Expression of NLRP3 inflammasome in BALB/c mice with imiquimod-induced psoriasis-like inflammation and therapeutic effect of mustard seed (Sinapis Alba Linn)].
Hu J; Yang R; Wen C; Li H; Zhao H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1394-8. PubMed ID: 24067228
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
6. Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod-induced psoriasis mouse model.
Tsurekawa Y; Morita M; Suico MA; Moriuchi M; Nakano Y; Piruzyan M; Takada M; Fukami S; Shuto T; Kai H
Exp Dermatol; 2018 Oct; 27(10):1092-1097. PubMed ID: 29928760
[TBL] [Abstract][Full Text] [Related]
7. TLR7-dependent eosinophil degranulation links psoriatic skin inflammation to small intestinal inflammatory changes in mice.
Kim HJ; Jang J; Na K; Lee EH; Gu HJ; Lim YH; Joo SA; Baek SE; Roh JY; Maeng HJ; Kim YH; Lee YJ; Oh BC; Jung Y
Exp Mol Med; 2024 May; 56(5):1164-1177. PubMed ID: 38689088
[TBL] [Abstract][Full Text] [Related]
8. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
10. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
12. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model.
Wu HH; Xie WL; Zhao YK; Liu JH; Luo DQ
Curr Vasc Pharmacol; 2016; 14(3):275-9. PubMed ID: 26733387
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of Psoriasis-Like Inflammation by PCSK9.
Luan C; Chen X; Zhu Y; Osland JM; Gerber SD; Dodds M; Hu Y; Chen M; Yuan R
J Invest Dermatol; 2019 Apr; 139(4):859-867. PubMed ID: 30395847
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
Pohin M; Guesdon W; Mekouo AA; Rabeony H; Paris I; Atanassov H; Favot L; Mcheik J; Bernard FX; Richards CD; Amiaud J; Blanchard F; Lecron JC; Morel F; Jégou JF
Eur J Immunol; 2016 Jul; 46(7):1737-51. PubMed ID: 27122058
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Zhang S; Liu X; Mei L; Wang H; Fang F
BMC Complement Altern Med; 2016 Aug; 16(1):334. PubMed ID: 27581210
[TBL] [Abstract][Full Text] [Related]
17. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
[TBL] [Abstract][Full Text] [Related]
18. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of matrix remodelling associated 7 (MXRA7) in psoriatic epidermis: Evidence for a protective role in the psoriasis imiquimod mouse model.
Ning J; Shen Y; Wang T; Wang M; Liu W; Sun Y; Zhang F; Chen L; Wang Y
Exp Dermatol; 2018 Sep; 27(9):1038-1042. PubMed ID: 29781547
[TBL] [Abstract][Full Text] [Related]
20. A Type III Effector NleF from EHEC Inhibits Epithelial Inflammatory Cell Death by Targeting Caspase-4.
Song T; Li K; Zhou W; Zhou J; Jin Y; Dai H; Xu T; Hu M; Ren H; Yue J; Liang L
Biomed Res Int; 2017; 2017():4101745. PubMed ID: 28593173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
